Vtv Therapeutics earnings were -$19.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VTVT earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$6.0M, up 18.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VTVT reported annual earnings of -$18.5M, with -8.8% growth.
What were Vtv Therapeutics's earnings last quarter?
Vtv Therapeutics (NASDAQ: VTVT) reported Q2 2025 earnings per share (EPS) of -$0.92, up 13.58% year over year. Total VTVT earnings for the quarter were -$6.05 million. In the same quarter last year, Vtv Therapeutics's earnings per share (EPS) was -$0.81.
As of the last Vtv Therapeutics earnings report, Vtv Therapeutics is currently losing money. Vtv Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$19.56 million, a 3.08% decrease year over year.
What was VTVT's earnings growth in the past year?
As of Vtv Therapeutics's earnings date in Q3 2025, Vtv Therapeutics's earnings has grown year over year. VTVT earnings in the past year totalled -$19.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.